+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Blood Processing Devices and Consumables Market Report and Forecast 2024-2032

  • PDF Icon

    Report

  • 160 Pages
  • February 2024
  • Region: Global
  • Expert Market Research
  • ID: 5941104

Global Blood Processing Devices and Consumables Market Outlook

The global blood processing devices and consumables market size was valued at USD 47.8 billion in 2023, driven by growing emphasis on automating blood processing to increase efficiency, and reduce errors across the globe. The market size is anticipated to grow at a CAGR of 7.7% during the forecast period of 2024-2032 to achieve a value of USD 92.8 billion by 2032.

Blood Processing Devices and Consumables: Introduction

Blood processing devices and consumables are essential tools in the collection, processing, and storage of blood and blood components. These include centrifuges, blood bags, filters, refrigerators, and freezers, designed to ensure the safety and integrity of blood for transfusions, research, and therapeutic purposes. They play a crucial role in separating blood into its components (red cells, plasma, platelets), removing contaminants, and preserving blood for future use. Adopting advanced technologies in blood processing enhances efficiency, safety, and the quality of blood products.

Key Trends in the Global Blood Processing Devices and Consumables Market

There's a growing emphasis on automating blood processing to increase efficiency, reduce errors, and ensure consistency in blood product quality. Integrated systems that combine multiple processing steps are becoming more common, streamlining operations in blood banks and hospitals.

Enhanced safety features and compliance with stringent regulatory standards are paramount. Devices and consumables are increasingly designed to minimize contamination risk and improve the safety of blood transfusions, with closed systems and advanced filtration technologies gaining prominence.

The industry is focusing on reducing environmental impact through more sustainable practices, including the development of eco-friendly consumables and energy-efficient devices.

Advanced data management solutions are being integrated into blood processing equipment to ensure traceability, manage inventory, and maintain detailed records of blood products, enhancing the overall safety and efficiency of blood supply chains.

There's a trend towards developing customizable solutions that can be adapted to different scales of operation, from small clinics to large blood processing centers, to accommodate varying demands and workflows.

Beyond traditional transfusion medicine, there's an increasing use of blood components in regenerative medicine and cell therapies, driving demand for specialized processing equipment and consumables tailored to these advanced applications.

Efforts to improve access to safe blood supplies in developing countries are shaping market dynamics, with an increased focus on portable and easy-to-use devices suitable for varied healthcare settings.

Global Blood Processing Devices and Consumables Market Segmentation

Market Breakup by Type

  • Blood Processing Devices
  • Blood Bank Freezers
  • Blood Grouping Analyzers
  • Blood Warmer
  • Blood Cell Processors
  • Other Blood Processing Devices
  • Blood Processing Consumables
  • Blood Bags
  • Blood Lancets
  • Vials
  • Blood Administration Sets
  • Others

Market Breakup by End User

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Other End Users

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global Blood Processing Devices and Consumables Market Overview

In North America, the market for blood processing devices and consumables is characterized by advanced healthcare infrastructure and stringent regulatory standards ensuring the quality and safety of blood products. The region sees a high adoption rate of innovative technologies for blood processing, driven by a strong focus on research and development. There's also a significant emphasis on automation and integrated systems to enhance efficiency and reliability in blood banks and healthcare facilities.

Europe's market benefits from comprehensive healthcare systems and a focus on safety and quality in transfusion medicine. The region is proactive in adopting new technologies and best practices in blood processing, supported by collaborative efforts across countries to standardize procedures and regulations. Environmental sustainability and reducing the carbon footprint of blood processing operations are emerging trends, influencing the adoption of energy-efficient devices and consumables.

The Asia-Pacific market is rapidly growing, driven by increasing healthcare expenditure, rising awareness about blood donation, and improving healthcare infrastructure. The demand for blood processing devices and consumables is expanding, particularly in emerging economies with growing populations. However, the region faces challenges related to diverse regulatory landscapes and the need for training and education among healthcare professionals on the latest blood processing techniques.

Global Blood Processing Devices and Consumables Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.
  • Abbott Laboratories
  • Becton Dickinson and Company
  • Roche Holdings AG
  • Danaher Corporation
  • Immucor, Inc.
  • Terumo Corporation
  • Haemonetics Corporation
  • Danaher Corporation
  • Grifols International
  • Thermo Fisher Scientific, Inc.
  • Teleflex Incorporated
  • Thermogenesis Holdings, Inc.
  • Maco Pharma
  • Biomerieux SA


This product will be delivered within 5-7 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Blood Processing Devices and Consumables Market Overview
3.1 Global Blood Processing Devices and Consumables Market Historical Value (2017-2023)
3.2 Global Blood Processing Devices and Consumables Market Forecast Value (2024-2032)
4 Global Blood Processing Devices and Consumables Market Landscape
4.1 Global Blood Processing Devices and Consumables Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Blood Processing Devices and Consumables Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Applications
5 Global Blood Processing Devices and Consumables Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Blood Processing Devices and Consumables Market Segmentation
6.1 Global Blood Processing Devices and Consumables Market by Type
6.1.1 Market Overview
6.1.2 Blood Processing Devices
6.1.2.1 Blood Bank Freezers
6.1.2.2 Blood Grouping Analyzers
6.1.2.3 Blood Warmer
6.1.2.4 Blood Cell Processors
6.1.2.5 Other Blood Processing Devices
6.1.3 Blood Processing Consumables
6.1.3.1 Blood Bags
6.1.3.2 Blood Lancets
6.1.3.3 Vials
6.1.3.4 Blood Administration Sets
6.1.3.5 Others
6.2 Global Blood Processing Devices and Consumables Market by End User
6.2.1 Market Overview
6.2.2 Hospitals and Clinics
6.2.3 Diagnostic Laboratories
6.2.4 Other End Users
6.3 Global Blood Processing Devices and Consumables Market by Region
6.3.1 Market Overview
6.3.2 North America
6.3.3 Europe
6.3.4 Asia Pacific
6.3.5 Latin America
6.3.6 Middle East and Africa
7 North America Blood Processing Devices and Consumables Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Blood Processing Devices and Consumables Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Blood Processing Devices and Consumables Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Others
10 Latin America Blood Processing Devices and Consumables Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Blood Processing Devices and Consumables Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Abbott Laboratories
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Becton Dickinson and Company
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Roche Holdings AG
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Danaher Corporation
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Immucor, Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Terumo Corporation
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Haemonetics Corporation
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Danaher Corporation
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Grifols International
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Thermo Fisher Scientific, Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Teleflex Incorporated
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Thermogenesis Holdings, Inc.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Maco Pharma
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Biomerieux SA
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
18 Global Blood Processing Devices and Consumables Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.

Companies Mentioned

  • Abbott Laboratories
  • Becton Dickinson and Company
  • Roche Holdings AG
  • Danaher Corporation
  • Immucor Inc.
  • Terumo Corporation
  • Haemonetics Corporation
  • Danaher Corporation
  • Immucor Inc.
  • Grifols Internationa
  • Thermo Fisher Scientific Inc.
  • Teleflex Incorporated
  • Thermogenesis Holdings Inc.
  • Maco Pharma
  • Biomerieux SA

Methodology

Loading
LOADING...

Table Information